0001615774-18-006001.txt : 20180629 0001615774-18-006001.hdr.sgml : 20180629 20180629160429 ACCESSION NUMBER: 0001615774-18-006001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180627 FILED AS OF DATE: 20180629 DATE AS OF CHANGE: 20180629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guse Kyle CENTRAL INDEX KEY: 0001566618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 18929316 MAIL ADDRESS: STREET 1: C/O ATOSSA GENETICS INC. STREET 2: 1616 EASTLAKE AVE. E SUITE 510 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA GENETICS INC CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 4 1 s111134_form4.xml 4 X0306 4 2018-06-27 0 0001488039 ATOSSA GENETICS INC ATOS 0001566618 Guse Kyle C/O ATOSSA GENETICS INC. 107 SPRING STREET SEATTLE WA 98104 0 1 0 0 CFO, Gen Counsel and Secretary Stock Option (right to buy) 2.38 2018-06-27 4 A 0 700000 0.00 A 2028-06-27 Common Stock 700000 700000 D Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones. /s/ Kyle Guse 2018-06-29